Rehmannia for Anti-Inflammatory

Research suggests that Rehmannia glutinosa and its bioactive constituents — particularly catalpol, rehmapicrogenin, and various polysaccharides — demonstrate anti-inflammatory properties across a range of laboratory and animal models, with proposed mechanisms including suppression of the NF-κB signaling pathway, inhibition of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, and modulation of oxidative stress pathways. The available evidence consists predominantly of preclinical studies (cell culture and animal experiments) along with several narrative reviews summarizing findings on catalpol and Rehmannia polysaccharides, and one very small, uncontrolled clinical trial involving a multi-herb formula that included Rehmannia as one of eleven ingredients, making it impossible to attribute the observed effects specifically to Rehmannia alone. One study from 2008 conducted in diabetic rats found that a Rehmannia extract meaningfully reduced the inflammatory marker C-reactive protein, and a 2012 bioassay-guided study identified rehmapicrogenin as a specific anti-inflammatory compound, though researchers noted that other unidentified constituents likely contribute to the overall effect. Overall, the body of research is directionally consistent in supporting anti-inflammatory activity, but the near-total absence of well-designed human clinical trials means that whether these effects translate meaningfully to people remains an open question.